Hepatitis C virus (HCV) infection can result in varied clinical outcomes including acute hepatitis, chronic hepatitis, cirrhosis, or the establishment of an asymptomatic carrier state which may persist for life. It is estimated that HCV establishes chronic infections in >50% of those infected and that about 0.5-1% of the population is infected, with a substantial fraction of these cases without associated risk factors. Recent studies have uncovered a strong association between chronic HCV infection and the development of hepatocellular carcinoma (HCL). Although defining the underlying mechanisms of this association presents a fascinating challenge for cancer researchers, the most direct approaches for reducing the incidence of this disease are 1) to prevent virus infection by developing effective vaccines and 2) to develop therapeutic agents directed against conserved viral targets to control and perhaps cure chronic infections. This proposal is aimed at understanding the molecular mechanisms of HCV replication with emphasis on elucidating viral targets for development of therapeutic agents and vaccines. The first section examines HCV polyprotein processing and virus-encoded enzymatic activities, with emphasis on isolation and characterization of the putative HCV serine proteinase. A byproduct of these studies will be the definition of mature HCV polypeptides produced by proteolysis. This information will allow future studies to be undertaken to assess the involvement of individual HCV products in establishment of chronic infections, virus-induced cytopathic effects, evasion of immunological surveillance, and to determine if these proteins play a direct role in the association of HCV with HCC. The second major focus is to construct full-length HCV cDNA clones and assay transcripts produced from these cloned templates for biological activity. If successful, the establishment of such a system would facilitate screening for effective antivirals, allow molecular genetic studies to further our understanding of HCV replication and host interactions, and might eventually allow engineering of attenuated candidate vaccine strains. The third area of investigation is to develop a novel technology and a set of reagents for studies on T-cell mediated immune responses to HCV infection in primates. This is important for two reasons. First, T-cell immunity may play a role in the ability of some individuals to limit and perhaps eliminate HCV infections. Second, if a set of conserved and protective T-cell epitopes can be identified, such information would aid in the design of potential vaccine strategies and in assessing their efficacy at eliciting appropriate immune responses in vivo.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA057973-02
Application #
3202263
Study Section
Special Emphasis Panel (SRC (66))
Project Start
1992-08-01
Project End
1996-07-31
Budget Start
1993-08-01
Budget End
1994-07-31
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Washington University
Department
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Laidlaw, Stephen M; Marukian, Svetlana; Gilmore, Rachel H et al. (2017) Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons. Gastroenterology 153:566-578.e5
Billerbeck, Eva; Wolfisberg, Raphael; Fahnøe, Ulrik et al. (2017) Mouse models of acute and chronic hepacivirus infection. Science 357:204-208
Moreno, Elena; Gallego, Isabel; Gregori, Josep et al. (2017) Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment. J Virol 91:
Luna, Joseph M; Michailidis, Eleftherios; Rice, Charles M (2016) Mopping up miRNA: An integrated HBV transcript disrupts liver homeostasis by sequestering miR-122. J Hepatol 64:257-259
Scheel, Troels K H; Luna, Joseph M; Liniger, Matthias et al. (2016) A Broad RNA Virus Survey Reveals Both miRNA Dependence and Functional Sequestration. Cell Host Microbe 19:409-23
Ramanan, Vyas; Trehan, Kartik; Ong, Mei-Lyn et al. (2016) Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies. Virology 494:236-47
Gu, Meigang; Rice, Charles M (2016) The Spring ?-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action. J Biol Chem 291:14499-509
Swanson, Michael D; Boudreaux, Daniel M; Salmon, Loïc et al. (2015) Engineering a therapeutic lectin by uncoupling mitogenicity from antiviral activity. Cell 163:746-58
Saeed, Mohsan; Andreo, Ursula; Chung, Hyo-Young et al. (2015) SEC14L2 enables pan-genotype HCV replication in cell culture. Nature 524:471-5
Luna, Joseph M; Scheel, Troels K H; Danino, Tal et al. (2015) Hepatitis C virus RNA functionally sequesters miR-122. Cell 160:1099-110

Showing the most recent 10 out of 117 publications